Rapid screening service for phosphatase enzymes offers drug selectivity testing against an expanding panel of phosphatase enzymes (currently 19 phosphatases)
Innova Biosciences has completed the development of a 'unique' rapid screening service for phosphatase enzymes.
Speedlead-P offers drug selectivity testing against an expanding panel of phosphatase enzymes (currently 19 phosphatases).
Percent inhibition or IC50 determinations are made for all submitted compounds.
Data is automatically analysed and subjected to rigorous, objective (ie software-determined) QC pass/fail.
An accelerated 48 screening service is also available.
